The responsibility rests with patients to contact CANSA for assistance. Read more...

Research Study – Evaluation of the Acceptability and Validity of the Serious Illness Conversation Guide in Oncology Patients in South Africa

The Universities of Cape Town and Stellenbosch invites eligible cancer patients, family members of cancer patients, or cancer care advocates survivors living in or around Cape Town to participate in a research study focused on clinical communication in advanced cancer patients.

The patients participating in this study can potentially benefit from having their goals and wishes for end-of-life care clarified in their own minds, which, if shared with their Health Care Practitioner and families could lead to improved end-of-life care for themselves.

Participants need to be:

  • residing in the Western Cape
  • able to communicate in either English or Afrikaans (to enable discussion in the group setting with facilitators)
  • have cancer or be a close relative or carer of someone with cancer or be a community advocate for cancer care
  • and be fit and able to attend a focus group meeting (of up to 8 people) at either Groote Schuur Hospital or Tygerberg Hospital in the next 2 months (current COVID guidelines will be adhered to).

Regrettably, due to the nature of this study being focussed on the local cultural context, non-South Africans will not be suitable for inclusion. Please note that participation in this study is voluntary and subject to signing consent.

Please send an SMS or WhatsApp message with the word FOCUS to 079 635 5893 if you would like to find out more about being part of one of the discussion groups.

Download study invitation flyers:

This research has been granted ethical approval from the University of Cape Town Human Research Ethics Committee.

Do you have a question?
Book a counselling session

CANSA Tele Counselling

 0800 22 6622 Toll Free
 072 197 9305 English and Afrikaans
 071 867 3530 Xhosa, Zulu, Sotho and Siswati

  Find Your Care Centre

About Us | Get in Touch

Sign up to receive news and updates: